全文获取类型
收费全文 | 252篇 |
免费 | 10篇 |
国内免费 | 1篇 |
专业分类
儿科学 | 7篇 |
妇产科学 | 2篇 |
基础医学 | 12篇 |
口腔科学 | 6篇 |
临床医学 | 24篇 |
内科学 | 133篇 |
皮肤病学 | 1篇 |
神经病学 | 1篇 |
特种医学 | 49篇 |
外科学 | 7篇 |
综合类 | 3篇 |
预防医学 | 4篇 |
药学 | 8篇 |
肿瘤学 | 6篇 |
出版年
2023年 | 2篇 |
2020年 | 2篇 |
2018年 | 1篇 |
2017年 | 2篇 |
2016年 | 1篇 |
2015年 | 2篇 |
2014年 | 3篇 |
2013年 | 4篇 |
2012年 | 1篇 |
2011年 | 3篇 |
2010年 | 1篇 |
2009年 | 7篇 |
2008年 | 4篇 |
2007年 | 3篇 |
2006年 | 3篇 |
2005年 | 4篇 |
2004年 | 4篇 |
2003年 | 6篇 |
2002年 | 11篇 |
2001年 | 5篇 |
2000年 | 11篇 |
1999年 | 4篇 |
1998年 | 15篇 |
1997年 | 11篇 |
1996年 | 8篇 |
1995年 | 10篇 |
1994年 | 14篇 |
1993年 | 19篇 |
1992年 | 3篇 |
1991年 | 2篇 |
1990年 | 1篇 |
1989年 | 10篇 |
1988年 | 19篇 |
1987年 | 16篇 |
1986年 | 11篇 |
1985年 | 7篇 |
1984年 | 7篇 |
1983年 | 7篇 |
1982年 | 6篇 |
1981年 | 3篇 |
1980年 | 2篇 |
1979年 | 2篇 |
1978年 | 2篇 |
1976年 | 3篇 |
1975年 | 1篇 |
排序方式: 共有263条查询结果,搜索用时 0 毫秒
261.
262.
OBJECTIVES: To delineate the costs of care of patients with Chronic Obstructive Pulmonary Disease (COPD) and respiratory failure and to compare them with those of other mechanically ventilated patients. DESIGN: A post hoc analysis of a prospective investigation. SETTING: Medical and coronary intensive care units (ICUs) of an 804-bed, university-based hospital. PATIENTS: A total of 300 mechanically ventilated patients, 44 with COPD and 256 others, were included. MEASUREMENTS AND MAIN RESULTS: Despite similar lengths of ICU stay (9 days) and mechanical ventilation (5.5 days COPD vs. 5 days other, p = .11), ICU respiratory care costs for patients with COPD were $2,422 ($1,157-$6,110) [median U.S. dollars (interquartile range)] vs. $1,580 ($738-$3,322) for the others (p = .01). Ventilator costs for COPD patients were $1,795 ($943-$5,782) vs. $1,574 ($613-$3,112) (p = .12). Total hospitalization respiratory care costs for COPD patients were higher, $4,064 ($2,422-$9,572) vs. $2,342 ($1,186-$4,591), (p = .0001), and 74.4% of the median difference in cost between COPD patients and others was accounted for by spontaneous nebulizers (p = .001), metered dose inhalers (p = .01), and pulse oximetry (p = .02). By using multiple linear regression analyses, we found that COPD remained associated with higher respiratory costs (p<.05). Respiratory Care was the third largest category of hospital costs after beds (27%) and pharmacy expenses (25%), and it comprised approximately 14% of total cost. Total hospital costs were large for both groups, but did not differ between COPD and the others [$24,217 ($16,211-$58,834) vs. $27,672 ($15,692-$53,766), respectively (p = .96)]. Linear regression analyses showed that only Acute Lung Injury score was significantly related to total ICU and hospital costs of care (p<.05). CONCLUSIONS: Costs of ICU and non-ICU respiratory care for patients with COPD are higher than costs of care for other mechanically ventilated patients. Although the increased cost of bronchodilators and oximetry in these patients may serve as target areas for reductions in respiratory care costs, it may also be true that these modalities of therapy and management are necessary and need to be used with even greater intensity to achieve better outcomes. The predominant contributions of bed and pharmacy costs in all of our patients with respiratory failure support research efforts addressing these aspects of care. 相似文献
263.